Status: Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
This study is being done to find out of NRM-823 is safe and can treat participants with locally advanced or metastatic solid tumors.
Participants needed: 150
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Normunity AccelCo, Inc.Updated: Feb 12, 2026Locations: 9
Eligibility criteria
Have histologically- or cytologically-diagnosed NSCLC (squamous or adenocarcinom... [+3]
Has received cytotoxic chemotherapy, biologic anticancer agents, checkpoint inhi... [+3]